Global Non-opioid Pain Patch Market to benefit from Rising Regulations on Opioid Prescriptions

There has been an alarming rise in the misuse and abuse of opioid in the past few years. The situation has necessitated the introduction of effective, safer, and non-addictive analgesics for pain relief. As chronic pain increasingly becomes one of the most common conditions for which patients require emergency medical care and medications, the development of non-opioid interventions such as pain patches has become critical. The massive rise in the number of opioid prescriptions dispended by retail pharmacies is testimony to this. According to the U.S. National Prescription Audit, there was a rise from 76 mn pharmacy prescriptions for opioid in 1997 to about 219 mn in 2011.

Healthcare bodies across the globe, concerned with the rising abuse of the medication, have put vast regulations on the way prescriptions are granted and ways of finding non-opioid therapeutics for relieving pain are being researched. The situation has provided a massive push to the global market for non-opioid pain patch.

Transparency Market Research (TMR) stated that the global non-opioid pain patch market will exhibit a 3.3% CAGR from 2016 to 2024, rising to a valuation of US$4,983.3 mn by 2024 from US$3,750 mn in 2015.

In this blog post, TMR analysts underline some of the key trends observed in the market recently and their potential impact on the future development of the market:

Despite the vast scope of rise in demand for non-opioid therapeutics for pain relief, why does the market seem to have moderate growth opportunities?

It is true that non-opioid pain patches have been challenged by a low rate of adoption across the globe. The key factor behind this is the more effective nature of oral pain relieving drugs. Oral drugs are known to provide relief in short durations with effect directly aimed at the central nervous system, which prevents the sensation of pain from spreading across the body. The demand for non-opioid pain patches is also negatively affected by the increasing preference of the global population towards implants for long-term effect. Minimally invasive procedures used for implant surgeries prove effective and are increasingly gaining prominence. Owing to these factors, the demand for non-opioid pain patches has suffered in the past few years.

Nevertheless, enormous opportunities can be seen in emerging economies wherein the cost-conscious consumer could prefer non-opioid pain patches over the costly implant treatments. Also, emerging economies in regions such as Asia Pacific are witnessing a mounting rise in lifestyle-induced chronic pain cases.

How competitive is the vendor landscape of the market?

The vendor landscape of the global non-opioid pain patch market has a moderate level of competition. Owing to the niche nature of the market in the broad pain relief therapeutics market, few companies are operating in the area. These limited number of players hold commanding positions owing to their brand names, making it difficult for new vendors to establish their businesses. Regional companies are focusing on collaboration strategies with leading pharmaceutical companies to improve their level of level of penetration in the overall market. 


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports